Modeling tau polymerization in vitro: a review and synthesis.
The major antigenic component of neurofibrillary pathology in a large number of neurodegenerative diseases consists of the microtubule-associated protein tau. It is currently unclear how tau protein makes the transition from an important component of the microtubule-based cytoskeleton to an insoluble polymerized state. In vitro techniques have been employed to study the polymerization of tau in an effort to understand the underlying molecular mechanisms responsible for this process. These efforts have resulted in the elucidation of roles played by the different parts of the molecule in the polymerization process. Here we discuss the advantages and disadvantages of the various techniques used to model tau polymerization and the discoveries arising from these techniques that have led to a better structural understanding of tau polymerization in relation to Alzheimer's disease and other tauopathies.
Gamblin
T Chris
TC
Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA. gamblin@ku.edu
Berry
Robert W
RW
Binder
Lester I
LI
D000544:Alzheimer Disease / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D008956:Models, Chemical; D008958:Models, Molecular; D011108:Polymers / Q000737:chemistry / Q000378:metabolism; D016875:tau Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
D011108:Polymers; D016875:tau Proteins